Sentinel Node in Colon Cancer

University Hospital, Strasbourg, France

Status: Unknown

Conditions: Colon Cancer

Treatments: Procedure: blue and isotopic detection of sentinel lymph nodes

Study type: Interventional

Funder types: Other

Identifiers

NCT00411112

3737

Details and patient eligibility

About

More than 20% of patients operated on for colon cancer without node metastasis will develop visceral metastases. The purpose of the study is to determine sentinel lymph nodes with two methods: blue injection and isotopic detection. Sentinel nodes will then be analyzed by immunohistochemy to detect micrometastases. No adjuvant therapy will be proposed to the patient if there are only node's micrometastases and survival will be analyzed in regard to the presence of these micrometastasis.

Enrollment: 140 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• adult
• colon cancer
• open surgery

Exclusion criteria

• emergency surgery
• metastases

Trial design

Primary purpose: Diagnostic

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)